What is the appropriate evaluation and management of primary amenorrhea in an adolescent female?

Management of Primary Amenorrhoea

Primary amenorrhoea requires a systematic diagnostic approach to exclude pregnancy, perform comprehensive hormonal evaluation (FSH, LH, estradiol, prolactin, TSH, free T4, testosterone, DHEA-S, and 8 AM 17-hydroxyprogesterone if hyperandrogenism suspected), conduct physical examination including external gynecologic assessment, and obtain pelvic imaging when indicated—followed by etiology-specific treatment targeting the underlying cause while addressing bone health, metabolic complications, and reproductive potential. 1

Diagnostic Evaluation

Initial Assessment

History must specifically address:

• Family history of primary ovarian insufficiency or delayed puberty
• History of chemotherapy, radiation therapy, or pelvic surgery
• Eating patterns, weight changes, and exercise intensity (screen for functional hypothalamic amenorrhea)
• Psychological stressors, anxiety, or depression
• Autoimmune conditions (thyroid disease, diabetes, Addison's disease, vitiligo, celiac disease)
• Fragile X syndrome or intellectual disability in male family members
• Anosmia (suggests Kallmann syndrome) 1

Physical examination priorities:

• Document Tanner staging (critical for determining if patient has reached expected pubertal milestones)
• Measure height, weight, BMI
• Assess for signs of hyperandrogenism: hirsutism, acne, male pattern alopecia, clitoromegaly
• Look for signs of hypoestrogenism: thin vaginal mucosa, bradycardia, cool extremities
• Check for acanthosis nigricans (insulin resistance)
• External gynecologic examination to rule out imperforate hymen or vaginal anomalies
• Bimanual examination in cases of primary amenorrhea to evaluate for Müllerian anomalies (or substitute with pelvic ultrasound if patient prefers) 1

Laboratory Workup

Mandatory initial hormonal panel:

• β-hCG (exclude pregnancy first)
• FSH, LH, estradiol
• Prolactin
• TSH, free T4
• Anti-Müllerian hormone (AMH) 1

Add if clinically indicated:

• Total testosterone and DHEA-S if hyperandrogenism present
• 8 AM 17-hydroxyprogesterone if late-onset congenital adrenal hyperplasia suspected
• Complete blood count, electrolytes, glucose, liver panel if eating disorder or chronic illness suspected 1

Interpretation patterns:

• Low/normal LH and FSH with low estradiol = Functional hypothalamic amenorrhea or hypothalamic-pituitary pathology
• Elevated FSH (>25 IU/L) with low estradiol = Primary ovarian insufficiency (repeat in 1 month to confirm) 2
• Elevated LH:FSH ratio with normal/high testosterone = Consider PCOS (but diagnosis problematic in adolescents—requires hyperandrogenism plus persistent oligomenorrhea) 3
• Elevated prolactin = Hyperprolactinemia (obtain MRI if significantly elevated)

Imaging

Pelvic ultrasound (transabdominal or transvaginal):

• Evaluate uterine and ovarian anatomy
• Assess for Müllerian anomalies
• Document ovarian morphology 1

Brain MRI indicated when:

• Elevated prolactin levels
• Low gonadotropins with low estradiol (rule out pituitary/hypothalamic mass)
• Neurological symptoms or visual field defects
• Anosmia present 1

Etiology-Specific Management

Functional Hypothalamic Amenorrhea (FHA)

This is the most common functional cause and requires:

Immediate interventions:

• Nutritional rehabilitation to achieve positive energy balance
• Reduce excessive exercise intensity/volume
• Cognitive behavioral therapy for eating disorders, stress, or anxiety
• Weight restoration to BMI >18.5 kg/m² (or higher if needed for individual patient)
• Address psychological stressors through counseling 1

Hormonal management:

• Do NOT use hormonal contraceptives as first-line in FHA—they mask the underlying problem and do not address bone health adequately
• Transdermal estradiol (100 mcg patch twice weekly) plus cyclic progesterone (200 mg days 1-12 of month) is preferred for bone protection if behavioral interventions fail after 6-12 months 1
• Monitor bone density with DXA scan at baseline and annually

Critical pitfall: Prescribing oral contraceptives to "regulate cycles" without addressing underlying energy deficit perpetuates the problem and provides false reassurance while bone loss continues 4

Polycystic Ovary Syndrome (PCOS)

Diagnosis in adolescents requires BOTH:

• Clinical and/or biochemical hyperandrogenism (after excluding other causes)
• Persistent oligomenorrhea (>45 days between cycles)
• Note: Polycystic ovarian morphology alone is NOT sufficient for diagnosis in adolescents 3

First-line treatment:

• Hormonal contraceptives for menstrual regulation, acne, and hirsutism (if patient has reached Tanner stage 4-5) 3
• Lifestyle modification (calorie-restricted diet and exercise) for overweight/obese patients—this is equally first-line 3

Second-line treatment:

• Metformin (1500-2000 mg daily) for metabolic abnormalities, menstrual irregularity, or if hormonal contraceptives contraindicated—particularly beneficial in adolescents with insulin resistance 3
• Provide contraception counseling if using metformin alone, as it may restore ovulation

Screen for comorbidities:

• Type 2 diabetes (fasting glucose, HbA1c, consider OGTT)
• Dyslipidemia
• Depression and anxiety
• Obstructive sleep apnea if obese
• Nonalcoholic fatty liver disease 3

Primary Ovarian Insufficiency (POI)

Confirmed by:

• FSH >25 IU/L on two occasions at least 1 month apart
• Low estradiol
• Age <40 years 2

Management priorities:

Hormone replacement therapy (mandatory):

• Transdermal estradiol 100 mcg patch twice weekly PLUS
• Cyclic micronized progesterone 200 mg days 1-12 monthly (or continuous if prefers amenorrhea)
• Continue until at least age 50-51 years (natural menopause age)
• This is NOT contraception—provide separate contraceptive method if sexually active 2

Additional workup:

• Karyotype (rule out Turner syndrome mosaicism, fragile X premutation)
• Screen for autoimmune conditions (thyroid antibodies, morning cortisol, calcium, consider adrenal antibodies)
• Bone density assessment
• Fertility counseling (spontaneous pregnancy possible in 5-10% despite diagnosis) 2

Anatomic Abnormalities

Imperforate hymen or transverse vaginal septum:

• Surgical excision/incision
• Urgent if hematocolpos causing pain 5

Müllerian agenesis (Mayer-Rokitansky-Küster-Hauser syndrome):

• Neovagina creation (progressive dilation or surgical) timed near anticipated sexual activity
• Karyotype typically 46,XX with normal ovarian function
• Fertility requires gestational carrier 5

Cervical aplasia with functional uterus:

• Complex surgical reconstruction (isthmo-neovagina anastomosis) or hysterectomy if unsuccessful
• High complication risk—refer to specialized center 5

Hyperandrogenic Disorders (Non-PCOS)

Late-onset congenital adrenal hyperplasia (21-hydroxylase deficiency):

• Confirmed by 8 AM 17-hydroxyprogesterone >200 ng/dL (or >1000 ng/dL after ACTH stimulation)
• Treatment: Hydrocortisone 10-15 mg daily (divided doses) or dexamethasone 0.25-0.5 mg nightly
• Monitor for glucocorticoid excess (weight gain, growth suppression) 4

Androgen-secreting tumors:

• Suspect if rapid virilization, testosterone >150 ng/dL, or DHEA-S markedly elevated
• Requires imaging (pelvic ultrasound, adrenal CT/MRI)
• Surgical excision 4

Special Populations

Athletes with Primary Amenorrhea

Recognize Relative Energy Deficiency in Sport (RED-S):

• Energy availability <30 kcal/kg fat-free mass/day causes hypothalamic suppression
• Requires reduction in training volume/intensity AND increased caloric intake
• Do not simply add calories without modifying exercise
• Monitor for stress fractures, low bone density
• Multidisciplinary team (sports medicine, nutrition, psychology) 6, 7

Adolescents with Eating Disorders

Primary amenorrhea may be presenting feature:

• Requires specialized eating disorder treatment program
• Medical stabilization takes priority
• Expect 6-12 months of weight restoration before menses return
• Family-based therapy most effective in adolescents
• Monitor for refeeding syndrome if severely malnourished 1, 7

Critical Management Principles

Bone health is paramount:

• Primary amenorrhea during adolescence occurs during peak bone mass accrual
• Bone loss may be irreversible if prolonged
• DXA scan indicated if amenorrhea >6 months
• Calcium 1300 mg daily, vitamin D 600-1000 IU daily
• Weight-bearing exercise (unless excessive exercise is the cause) 1

Avoid common pitfalls:

• Do NOT prescribe oral contraceptives without determining etiology—this masks the diagnosis and provides false reassurance
• Do NOT delay evaluation—primary amenorrhea by age 15 (or 3 years post-thelarche) requires immediate workup
• Do NOT assume "constitutional delay" without proper evaluation—organic pathology must be excluded
• Do NOT use combined hormonal contraceptives in FHA as first-line—address underlying energy deficit first 1, 4, 3

Fertility counseling:

• Many causes of primary amenorrhea are treatable with restoration of fertility potential
• Even in POI, 5-10% achieve spontaneous pregnancy
• Oocyte cryopreservation should be discussed in appropriate candidates
• Early diagnosis improves reproductive outcomes 2, 8